- Syndax Pharmaceuticals Inc SNDX shares jumped 40.5 percent to $13.19 after the company reported the advancement of ENCORE 601 in non-small cell lung cancer patients with disease progression on or after PD-1 therapies.
- Cemtrex Inc CETX shares climbed 36.5 percent to $4.30 after the company disclosed that it has received over $21 million in new orders in April.
- Red Robin Gourmet Burgers, Inc. RRGB shares surged 19.7 percent to $69.45 as the company reported upbeat results for its first quarter. Bank of America upgraded Red Robin from Neutral to Buy.
- China Commercial Credit Inc CCCR shares climbed 17.5 percent to $2.35.
- Omeros Corporation OMER shares rose 14.6 percent to $17.13 as the company reported the completion of IgA nephropathy cohort in OMS721 Phase 2 clinical trial.
- Pyxis Tankers Inc PXS gained 14.4 percent to $1.59. Pyxis Tankers is scheduled to release unaudited results for the three months ended March 31, 2017 on May 18, 2017.
- Helios and Matheson Analytics Inc HMNY shares surged 14 percent to $2.54.
- Coherus Biosciences Inc CHRS shares rose 8 percent to $23.80. Coherus BioSciences disclosed that it prevailed in ‘135 IPR decision.
- Qiwi PLC QIWI gained 7.7 percent to $21.40 after reporting strong quarterly results.
- Jack in the Box Inc. JACK shares gained 7.3 percent to $109.29 after the company posted better-than-expected earnings for its second quarter. The company also disclosed that it has retained Morgan Stanley to evaluate potential alternatives for Qdoba.
- xG Technology Inc XGTI shares climbed 7 percent to $2.16.
- BioDelivery Sciences International, Inc. BDSI gained 6.4 percent to $2.08. Cantor Fitzgerald upgraded BioDelivery Sciences from Neutral to Overweight.
- Citi Trends, Inc. CTRN climbed 3.2 percent to $18.44 as the company posted in-line quarterly earnings and raised its quarterly dividend to $0.08 per share.
- Target Corporation TGT shares rose 3 percent to $56.12 after the company reported stronger-than-expected results for its first quarter.
- Colgate-Palmolive Company CL shares rose 3 percent to $73.71 after the NY Post reported that the company might be up for sale for $100 per share.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in